Clinical Report: Vascular Cell States in Marfan Syndrome

Overview

Revise to emphasize the clinical relevance of protein markers in aneurysm development.

Background

Marfan syndrome is a genetic disorder characterized by connective tissue abnormalities, leading to severe cardiovascular complications, particularly aortic aneurysms. Understanding the cellular changes in the aortic wall is crucial for developing targeted therapies and improving patient outcomes. Recent advancements in single-cell proteomics provide a novel approach to dissecting the complex cellular landscape associated with this condition.

Data Highlights

Key Findings

• Identification of 16 distinct cell groups in the aortic wall, including seven smooth muscle cell subtypes.
• Altered smooth muscle cell states were more prevalent in Marfan tissue, marked by proteins such as LRP1 and PRSS2.
• Endothelial cells exhibited signs of endothelial-to-mesenchymal transition, with reduced adhesion proteins and increased smooth muscle markers.
• Multiplexed spatial proteomics confirmed the presence of Marfan-associated markers in tissue samples.
• Integration of proteomic and transcriptomic data revealed additional Marfan-associated cell states not fully captured by RNA sequencing alone.

Clinical Implications

The identification of specific protein markers in vascular cells may provide new targets for therapeutic intervention in Marfan syndrome. Clinicians should consider these findings when assessing aortic health and potential aneurysm development in affected patients.

Conclusion

The study enhances our understanding of the cellular dynamics in Marfan syndrome and underscores the importance of single-cell proteomics in revealing disease-specific vascular changes. Further research is warranted to explore the functional implications of these newly identified cell states.

References

1. The Analytical Scientist, 2026 -- Proteomic Profiling Defines Vascular Cell States
2. Optometric Management, 2008 -- Case Study: Multiple Traumas Complicate Genetic Disorder
3. Pediatric Cardiology, 2018 -- Comparative Analysis of Cardiovascular Symptoms in Marfan Syndrome Among Pediatric and Adult Populations
4. Clinical Research in Cardiology, 2023 -- Preventive Benefits of Angiotensin Receptor Blockers in Pediatric Patients with Genetic Aortopathies: Timing is Key
5. American College of Cardiology, 2022 -- 2022 ACC/AHA Aortic Disease Guideline Key Perspectives: Part 2 of 2
6. PubMed -- Atenolol versus losartan in children and young adults with Marfan's syndrome
7. American College of Cardiology, 2024 -- FBN1-Related Marfan Syndrome in Children: Key Points
8. 2022 ACC/AHA Aortic Disease Guideline Key Perspectives: Part 2 of 2 - American College of Cardiology
9. Atenolol versus losartan in children and young adults with Marfan's syndrome - PubMed
10. FBN1-Related Marfan Syndrome in Children: Key Points - American College of Cardiology